Shaffer, David R

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Balar, A. V., Galsky, M. D., Rosenberg, J. E., Powles, T., Petrylak, D. P., Bellmunt, J., Loriot, Y., Necchi, A., Hoffman-Censits, J., Perez-Gracia, J. L., et al. (2017) · The Lancet

Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers

Cited by 2,199

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature

Telomeres, Telomerase, and SenescenceCancer-related Molecular Pathways

Cited by 1,993

Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion

Wang, G., Lunardi, A., Zhang, J., Chen, Z., Ala, U., Webster, K. A., Tay, Y., Gonzalez-Billalabeitia, E., Egia, A., Shaffer, D. R., et al. (2013) · Nature Genetics

Prostate Cancer Treatment and ResearchTelomeres, Telomerase, and Senescence

Cited by 137

Physical Illness and Depression in Older Adults: A Handbook of Theory, Research, and Practice

Williamson, G. M., Shaffer, D. R., & Parmelee, P. A. (2000) · The Plenum Series in Social/Clinical Psychology

Aging, Health, and DisabilityHealth and Well-being Studies

Cited by 59

Short-term results under three different immunosuppressive regimens at one center

Schaefer, H. M., Kizilisik, A. T., Feurer, I., Nylander, W. A., Langone, A. J., Helderman, J. H., & Shaffer, D. (2006) · Transplantation Proceedings

Renal Transplantation Outcomes and TreatmentsTransplantation: Methods and Outcomes

Cited by 20